Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6.
about
Mannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibodyCoevolution of activating and inhibitory receptors within mammalian carcinoembryonic antigen familiesRetargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.Labeling Cell Surface GPIs and GPI-Anchored Proteins through Metabolic Engineering with Artificial Inositol Derivatives.Empirical Bayes conditional independence graphs for regulatory network recovery.Targeted killing of colorectal cancer cell lines by a humanised IgG1 monoclonal antibody that binds to membrane-bound carcinoembryonic antigen.Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.Carcinoembryonic Antigen Expression and Resistance to Radiation and 5-Fluorouracil-Induced Apoptosis and AutophagyUsefulness of traditional serum biomarkers for management of breast cancer patients.High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer.Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies.Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer.Regulation of carcinoembryonic antigen release from colorectal cancer cells.Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression.DNA damaging agent-based antibody-drug conjugates for cancer therapyPharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells
P2860
Q28478285-56A43C78-D0ED-4858-B068-C442ED07C5EFQ28748645-BA9ADB2E-5F28-4A55-A1C3-CDB2CA5C95C0Q34120709-C812627A-808D-47C8-AFC9-D0C9B6228EA2Q35954889-CDEC7875-9DED-46A2-BE4B-01A7C885841CQ36105808-08EF1101-0564-4812-A9D3-E9F065DFD9D6Q36608573-2A081CD4-2965-4DFA-BC02-04E71ED235EDQ37038409-CB42309B-0603-4CBD-933F-1A8A031BC2AFQ37099595-E6F48C98-F38B-4D07-8615-B85AA55923B3Q37375636-C04BEF84-5A05-4B85-9925-84AB4ECCA500Q38788262-0AA63CC6-1213-42EE-8CD7-889012EA926FQ38846339-EA9366C3-15DF-48B3-BFC0-104EBCEC4870Q38946429-CD334021-A3A5-43E3-9A60-6E7C8952F4E1Q39051520-CA068F40-5482-4DE7-B5FB-A6BB185821D4Q39513464-77E1A578-2DAA-4A99-B1AB-83FD713748EFQ47432914-E32090BC-1165-48AD-91EF-9BF34B10587BQ57192403-CB7506C8-2A32-4BE7-B803-3567A9463CC7Q58801325-8AA4F795-3A10-4EAD-BF40-F42D6112F9D3
P2860
Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Recent advances in the tumour ...... y members CEACAM5 and CEACAM6.
@ast
Recent advances in the tumour ...... y members CEACAM5 and CEACAM6.
@en
type
label
Recent advances in the tumour ...... y members CEACAM5 and CEACAM6.
@ast
Recent advances in the tumour ...... y members CEACAM5 and CEACAM6.
@en
prefLabel
Recent advances in the tumour ...... y members CEACAM5 and CEACAM6.
@ast
Recent advances in the tumour ...... y members CEACAM5 and CEACAM6.
@en
P2860
P356
P1433
P1476
Recent advances in the tumour ...... ly members CEACAM5 and CEACAM6
@en
P2093
C P Stanners
P2860
P356
10.3747/CO.2007.109
P577
2007-04-01T00:00:00Z